XML 94 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock Plans
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Plans

6. Stock Plans

The Company’s Amended and Restated 2006 Omnibus Incentive Plan (the “Plan”) permits the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other share-based awards to its directors, employees and consultants. At December 31, 2014, approximately 4.4 million shares of common stock remained available for issuance pursuant to future grants of awards under the 2006 Plan (with a limit of approximately 0.9 million shares available for awards other than stock options or stock appreciation rights).

 

Stock option awards are generally granted with an exercise price equal to the market price of the Company’s stock at the date of grant and generally expire ten years after the date of grant. Generally, stock options granted to non-employee directors are exercisable after one year from the date of grant, while options granted to employees are exercisable one to four years from the date of grant. The Company records compensation expense equal to the fair value of each stock option award granted on a straight line basis over the option’s vesting period. The fair value of each option award is estimated on the date of grant using the Black-Scholes-Merton option pricing formula that uses the assumptions noted in the following table. Expected volatilities are based on the historical volatility of the Company’s stock. The Company uses historical data to estimate expected option exercise and employee termination patterns within the valuation model. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

The Company granted no options during 2014 or 2013. The weighted average for key assumptions used in determining the fair value of options granted in 2012 are as follows:

 

Expected volatility

     70.6

Weighted-average expected volatility

     70.6

Expected dividends

     —     

Expected term (in years)

     5.2   

Risk-free rate

     0.9

A summary of stock option activity under the Company’s equity incentive plans as of December 31, 2014 and changes during the year ended December 31, 2014 is presented below:

 

           Weighted  
           Average  
     Number of     Exercise  

Stock Options

   Shares     Price  

Outstanding at January 1, 2014

     872,049      $ 25.99   

Granted

     —          —     

Exercised

     (572,337     23.56   

Canceled

     (17,410     45.25   
  

 

 

   

Outstanding at December 31, 2014

     282,302        30.88   
  

 

 

   

Exercisable at December 31, 2014

     153,289        35.58   
  

 

 

   

The weighted average remaining contractual term of options outstanding and exercisable as of December 31, 2014 was 3.9 and 1.5 years, respectively. The aggregate intrinsic value of options outstanding and exercisable as of December 31, 2014 was $6.4 million and $2.8 million, respectively. The weighted-average grant-date fair value of options granted during 2012 was $14.34. The total intrinsic value of options exercised during 2014, 2013, and 2012 was $13.0 million, $4.3 million, and $21.5 million, respectively.

The Plan also provides for the award of restricted stock and restricted stock units (“Restricted Stock Awards”). Restricted Stock Awards granted to employees vest one to four years from the date of grant, and Restricted Stock Awards granted to non-employee directors vest after one year from the date of grant, unless the recipient chooses to defer the vesting for a period of time. The fair value of Restricted Stock Awards is determined based on the market price of the Company’s stock at the date of grant. The Company generally records compensation expense equal to the fair value of each Restricted Stock Award granted over the vesting period. The weighted-average grant-date fair value of Restricted Stock Awards granted during 2014, 2013, and 2012 was $41.61, $43.56, and $33.57, respectively.

 

A summary of the status of the Company’s Restricted Stock Awards as of December 31, 2014 and changes during the year ended December 31, 2014, is presented below:

 

           Weighted  
           Average  
           Grant-Date  

Restricted Stock Awards

   Shares     Fair Value  

Nonvested shares at January 1, 2014

     610,227      $ 34.20   

Granted

     155,478        41.61   

Vested

     (166,435     31.54   

Canceled

     (9,407     41.47   
  

 

 

   

Nonvested shares at December 31, 2014

     589,863        36.61   
  

 

 

   

The fair value of all Restricted Stock Awards that vested during 2014, 2013 and 2012 was $7.0 million, $3.2 million and $15.6 million, respectively.

As of December 31, 2014, there was $7.9 million of total unrecognized compensation cost related to stock options and restricted stock units granted under the Company’s equity incentive plans. That cost is expected to be recognized over a weighted-average period of 2.2 years.

In 2012, in connection with the termination of certain employee positions as a result of the REIT conversion discussed in Note 2, the Company cancelled approximately 167,500 stock options with a weighted average exercise price of $22.02 and approximately 401,000 restricted stock units with a weighted average grant date fair value of $29.76 per award. As a result of these cancellations, the Company reversed approximately $2.1 million in compensation costs during 2012, which are included in REIT conversion costs in the accompanying consolidated statements of operations.

The compensation cost that has been charged against pre-tax income for all of the Company’s stock-based compensation plans, including the reversal of compensation costs discussed above, was $5.8 million, $11.6 million, and $9.0 million for 2014, 2013, and 2012, respectively. The total income tax benefit recognized in the accompanying consolidated statements of operations for all of the Company’s stock-based employee compensation plans was $1.9 million, $3.0 million, and $3.2 million for 2014, 2013, and 2012, respectively.

Cash received from option exercises under all stock-based employee compensation arrangements for 2014, 2013, and 2012 was $6.9 million, $5.2 million, and $25.1 million, respectively. The actual tax benefit realized from exercise, vesting or cancellation of the stock-based employee compensation arrangements during 2014, 2013, and 2012 totaled $3.2 million, $1.0 million, and $5.2 million, respectively, and is reflected as an adjustment to either additional paid-in capital in the accompanying consolidated statements of stockholders’ equity or as a reduction to deferred tax liabilities in the accompanying consolidated balance sheets.